CD3 Receptor Agonists [MoA] - N0000175618

Pharmacologic Class Information

Pharmacologic Code N0000175618
Pharmacologic Name CD3 Receptor Agonists
Pharmacologic Uses
  • bispecific CD19-directed CD3 T-cell engager
  • bispecific gp100 peptide-HLA-directed CD3 T cell engager
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with CD3 Receptor Agonists

The following table contains 1 products whose active ingredient are classified under the same pharmacologic class CD3 Receptor Agonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
80446-401Kimmtrak Non-Proprietary Name: TebentafuspInjection, Solution, ConcentrateIntravenousImmunocore Commercial LlcACTIVE